These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 2883057

  • 1. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia.
    Klaff LJ, Taborsky GJ.
    Diabetes; 1987 May; 36(5):592-6. PubMed ID: 2883057
    [Abstract] [Full Text] [Related]

  • 2. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ.
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [Abstract] [Full Text] [Related]

  • 3. Role of pancreatic somatostatin in determining glucagon response to arginine and morphine.
    Klaff LJ, Taborsky GJ.
    Am J Physiol; 1987 Jun; 252(6 Pt 1):E751-5. PubMed ID: 2884887
    [Abstract] [Full Text] [Related]

  • 4. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
    Greenbaum CJ, Havel PJ, Taborsky GJ, Klaff LJ.
    J Clin Invest; 1991 Sep; 88(3):767-73. PubMed ID: 1679440
    [Abstract] [Full Text] [Related]

  • 5. Direct quantification of norepinephrine spillover and hormone output from the pancreas of the conscious dog.
    Dunning BE, Scott MF, Neal DW, Cherrington AD.
    Am J Physiol; 1997 May; 272(5 Pt 1):E746-55. PubMed ID: 9176171
    [Abstract] [Full Text] [Related]

  • 6. Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue.
    Taborsky GJ, Porte D.
    Am J Physiol; 1981 Apr; 240(4):E407-13. PubMed ID: 6111928
    [Abstract] [Full Text] [Related]

  • 7. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H, Dobbs R, Unger RH.
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [Abstract] [Full Text] [Related]

  • 8. A new benzothiadiazine derivative, LN 5330: effects on pancreatic hormones.
    Hillaire-Buys D, Ribes G, Blayac JP, Loubatières-Mariani MM.
    Diabetologia; 1984 Dec; 27(6):583-6. PubMed ID: 6152237
    [Abstract] [Full Text] [Related]

  • 9. Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion.
    Kaneto A, Kajinuma H, Kaneko T, Kosaka K.
    Metabolism; 1978 Aug; 27(8):901-10. PubMed ID: 209286
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin analogs inhibit somatostatin release.
    Ipp E, Rivier J, Dobbs RE, Brown M, Vale W, Unger RH.
    Endocrinology; 1979 May; 104(5):1270-3. PubMed ID: 436775
    [Abstract] [Full Text] [Related]

  • 11. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS, Lickley L, Jokay M, Efendic S, Vranic M.
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [Abstract] [Full Text] [Related]

  • 12. Effects of pancreatic noradrenaline infusion on basal and stimulated islet hormone secretion in the dog.
    Ahrén B, Taborsky GJ.
    Acta Physiol Scand; 1988 Feb; 132(2):143-50. PubMed ID: 2906499
    [Abstract] [Full Text] [Related]

  • 13. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1). Effects on basal release of insulin and glucagon.
    Ahrén B, Veith RC, Taborsky GJ.
    Endocrinology; 1987 Jul; 121(1):323-31. PubMed ID: 3297643
    [Abstract] [Full Text] [Related]

  • 14. P2 purinoceptor agonists stimulate somatostatin secretion from dog pancreas.
    Bertrand G, Gross R, Ribes G, Loubatières-Mariani MM.
    Eur J Pharmacol; 1990 Jul 03; 182(2):369-73. PubMed ID: 1975783
    [Abstract] [Full Text] [Related]

  • 15. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T, Röjdmark S, Bloom G, Chou MC, Field JB.
    Endocrinology; 1980 Jan 03; 106(1):220-30. PubMed ID: 7349954
    [Abstract] [Full Text] [Related]

  • 16. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A, Märki F, Keller U.
    Regul Pept; 1982 Aug 03; 4(3):117-26. PubMed ID: 6127755
    [Abstract] [Full Text] [Related]

  • 17. Effect of theophylline on insulin, glucagon and somatostatin secretion from the isolated rat pancreatico-duodenal preparation.
    Kudo M, Kimura K, Masuda M, Sasaki S, Sawano S, Takebe K.
    Endocrinol Jpn; 1981 Feb 03; 28(1):9-16. PubMed ID: 6113955
    [Abstract] [Full Text] [Related]

  • 18. Gastrin releasing peptide stimulates the secretion of insulin, but not that of glucagon or somatostatin, from the isolated perfused dog pancreas.
    Hermansen K, Ahrén B.
    Acta Physiol Scand; 1990 Feb 03; 138(2):175-9. PubMed ID: 1969219
    [Abstract] [Full Text] [Related]

  • 19. Effects of exogenous insulin, glucagon, and somatostatin on islet hormone secretion in the perfused chicken pancreas.
    Honey RN, Fallon MB, Weir GC.
    Metabolism; 1980 Dec 03; 29(12):1242-6. PubMed ID: 6109226
    [Abstract] [Full Text] [Related]

  • 20. Failure of human and mouse leptin to affect insulin, glucagon and somatostatin secretion by the perfused rat pancreas at physiological glucose concentration.
    Leclercq-Meyer V, Malaisse WJ.
    Mol Cell Endocrinol; 1998 Jun 25; 141(1-2):111-8. PubMed ID: 9723892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.